BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 1999
View Archived Issues
DiagnoCure develops diagnostic for metastatic prostate cancer cells
Read More
SBIR grant to Genetronics for gene therapy delivery research
Read More
Steroidogenesis inhibitor tested in mouse model of hereditary blindness
Read More
FDA requires further info about Hepagene vaccine
Read More
AIDSVAX enters clinical trials at U. of Pittsburgh
Read More
Merger plans for Synthelabo and Sanofi
Read More
Potent and specific FTase inhibitor presented by Biomeasure
Read More
Merck presents protein farnesyltransferase inhibitor in phase I testing
Read More
U.S. is country of first launch for single-isomer bronchodilator
Read More
PEG-rMETase, a promising new approach to cancer therapy
Read More
Preparation, compositions and administration of new carrier compounds reported by Emisphere
Read More
Fujirebio presents pyrimidine-based compounds useful for hypoxemia
Read More
Neurokinin antagonists for IBS synthesized and evaluated at Solvay
Read More
Schering-Plough investigators discover water-soluble salt of antifungal azole
Read More
Novel water-soluble camptothecin analogue suitable for formulation in liposomes
Read More
Sugen presents preclinical data for SU-6668 at AACR meeting
Read More
In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting
Read More
Profile of ZD-4190, a potent VEGF receptor tyrosine kinase inhibitor and antiangiogenic agent
Read More
News from AACR: Abbott researchers report findings on farnesyltransferase inhibitors
Read More
TAS-106, a promising antitumor nucleoside profiled at AACR meeting
Read More
Ebastine is not approvable, FDA tells RPR
Read More
Ontogen's OC144-093 reported at AACR meeting to merit further clinical testing
Read More
Higher dose of Rebif approved in E.U. for multiple sclerosis
Read More
Antisense oligonucleotides targeting Bcl-x developed and evaluated at Isis
Read More
Elan holds pre-NDA meeting concerning ziconotide
Read More
NovoSeven reaches the U.S. hemophilia market
Read More
New distamycin derivative PNU-166196 exerts both antiproliferative and apoptotic effects
Read More
Celtrix and Elan form joint venture for osteoporosis therapy
Read More
